Retatrutide

Description

Retatrutide is a synthetic triagonist peptide that simultaneously targets the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). It is designated a GLP-1/GIP/Glucagon triple receptor agonist in preclinical literature.

Current research interest centers on retatrutide’s multi-receptor activity profile and its effects on energy homeostasis, lipid metabolism, and glycemic regulation in in-vitro and animal model settings. Peer-reviewed preclinical studies have examined its receptor binding kinetics and downstream signaling pathways across all three target receptors.

Supplied as: Lyophilized powder, sealed vial Purity: ≥99% (HPLC verified) Testing: Independent third-party mass spectrometry and HPLC per batch Origin: United States Storage: −20°C, away from light and moisture Reconstitution: Bacteriostatic water (not included)

For research use only. Not for human or animal administration. Must be handled by a qualified researcher in a licensed laboratory setting. This product is not approved by the FDA and is not intended for diagnostic or therapeutic use.